157 related articles for article (PubMed ID: 36137754)
1. Is it Time to Re-Evaluate Our Experimental Approach to Studying Diffuse Podocytopathies?
Watts AJB; Weins A
J Am Soc Nephrol; 2022 Nov; 33(11):1959-1960. PubMed ID: 36137754
[No Abstract] [Full Text] [Related]
2. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
[TBL] [Abstract][Full Text] [Related]
3. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
Ahn W; Bomback AS
Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
[TBL] [Abstract][Full Text] [Related]
4. Nephrinuria and podocytopathies.
Kostovska I; Trajkovska KT; Topuzovska S; Cekovska S; Labudovic D; Kostovski O; Spasovski G
Adv Clin Chem; 2022; 108():1-36. PubMed ID: 35659057
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the podocytes in urine in the nephrotic syndrome in childhood].
Spadło A; Wyka K; Kowalewska-Pietrzak M; Bodalski J
Pol Merkur Lekarski; 2007 Apr; 22(130):254-7. PubMed ID: 17684921
[TBL] [Abstract][Full Text] [Related]
7. Pediatric nephrotic syndrome: from the simple to the complex.
Lane JC; Kaskel FJ
Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
9. Podocytopathies.
Kopp JB; Anders HJ; Susztak K; Podestà MA; Remuzzi G; Hildebrandt F; Romagnani P
Nat Rev Dis Primers; 2020 Aug; 6(1):68. PubMed ID: 32792490
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
Mundel P
Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
[No Abstract] [Full Text] [Related]
11. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
Liu J; Wang W
Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
[TBL] [Abstract][Full Text] [Related]
13. The role of B7-1 in proteinuria of glomerular origin.
Novelli R; Benigni A; Remuzzi G
Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
[TBL] [Abstract][Full Text] [Related]
14. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
[TBL] [Abstract][Full Text] [Related]
15. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
16. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review.
Franceschini N; North KE; Kopp JB; McKenzie L; Winkler C
Genet Med; 2006 Feb; 8(2):63-75. PubMed ID: 16481888
[TBL] [Abstract][Full Text] [Related]
17. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
18. The first identified heterozygous nonsense mutations in podocalyxin offer new perspectives on the biology of podocytopathies.
Refaeli I; Hughes MR; McNagny KM
Clin Sci (Lond); 2019 Feb; 133(3):443-447. PubMed ID: 30737302
[TBL] [Abstract][Full Text] [Related]
19. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
20. Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.
Akchurin O; Reidy KJ
Pediatr Nephrol; 2015 Feb; 30(2):221-33. PubMed ID: 24584664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
